Metabolix, Inc. announced that company's CEO Joseph Shaulson is stepping down from his current executive responsibilities and will provide transition support to the management team through the end of 2016. He will also remain on the company's board of directors. Johan van Walsem, Metabolix COO, has been leading the wind down of the company's biopolymer operations and transfer of biopolymer assets to CJ CheilJedang.

He is expected to leave the company at the end of October 2016. Going forward, Yield10 Bioscience will be led by: Oliver (Olly) Peoples, Ph.D., President and Chief Executive Officer: Dr. Peoples is an experienced entrepreneur and biotechnology executive with 30 years of experience in science and technology innovation. He initiated Metabolix crop science programs over a decade ago and more recently, spearheaded the development of Yield10's research and business focus.

Kristi Snell, Ph.D., Vice President, Research and Chief Science Officer: Dr. Snell has more than 20 years of relevant experience and is an industry recognized expert in metabolic engineering of plants and microbes for the production of novel products and increased plant yield. Dr. Snell will be responsible for leading research and development activities, intellectual property development, government grant programs, small scale field tests and larger scale field trials. Charles (Chuck) Haaser, Vice President, Finance and Chief Accounting Officer: Mr. Haaser has more than 30 years of senior accounting management and executive experience with public technology-based companies.

Mr. Haaser joined Metabolix in 2008 as Corporate Controller, and was named chief accounting officer in 2014. Lynne Brum, Vice President, Planning and Communications: Ms. Brum has more than 25 years of experience in the biotechnology industry. Ms. Brum joined Metabolix in 2011 as vice president of marketing and corporate communications.

She also previously served for 13 years at Vertex Pharmaceuticals where she was responsible for investor relations and corporate communications and served in additional roles including financial planning and corporate development. Ms. Brum will be responsible for strategic planning, investor relations and corporate communications as well as coordinating various corporate activities such as human resources, IT, legal and facilities.